title: Is there really a need for anti-coagulant prophylaxis for CVC-related thrombotic complications in pediatric oncological-hematological diseases?
authors.forename: Simone
authors.initials: S
authors.lastname: Cesaro
authors.forename: Roberta
authors.initials: R
authors.lastname: Corrò
authors.forename: Piergiorgio
authors.initials: P
authors.lastname: Gamba
authors.forename: Giovanni Franco
authors.initials: GF
authors.lastname: Zanon
mesh_terms: D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D002648:Child; D019337:Hematologic Neoplasms / Q000628:therapy; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000628:therapy; D013923:Thromboembolism / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D015912:Thrombolytic Therapy